Nano-X Imaging Reports Cost Cuts Amid Shrinking Cash Reserves
On September 9, Nano-X Imaging (NASDAQ:NNOX) reported second-quarter results showing a 37% year-over-year revenue increase to $4.2 million, driven by the consolidation of its Nanox Health IT business and growth in teleradiology services. However, the company also recorded a significant impairment charge of $40.7 million due to declining share prices and lower AI unit forecasts, which led to a GAAP net loss of $55.5 million for the quarter. Despite these losses, Nano-X is implementing cost-cutting measures including outsourcing chip manufacturing in South Korea, reducing headcount by 67% there and trimming Israeli staff by 15%, as well as shifting production to third-party partners. These actions are expected to save $2 million annually starting in 2027. The company’s cash reserves have dropped from $60 million at the end of December 2025 to $31.4 million, raising concerns about its ability to continue operations. Nano-X is also expanding through distribution partnerships and leveraging new Medicare codes for AI-based diagnostic tools. A pilot study with Cedars-Sinai showed promising results in detecting aortic valve calcification using the company’s cardiac AI tool.
Tickers: $NNOX
Topics: AI and software cash burn cost cutting revenue growth teleradiology